Pharma Blog Watch
Caps
on Medicare Drug Benefits the Downside (DrugWonks.com)
There are
obvious negatives to capping costs for Medicare benefits, writes blogger Peter
Pitts. In a concise and curt entry, Pitts cites a recent New England Journal
of Medicine article detailing the financial and clinical outcomes of a price-capped
study, and decries the causes of the study's largely unfavorable results.
Cancer
Treatments and Drug Resistance (In the Pipeline)
What are the benefits
and detriments of all the new cancer therapies that have emerged in recent years?
Blogger Derek Lowe discusses oncology treatments, focusing on the issue of drug
resistance, in his entry.
'Restless
Brush Syndome' in recent RLS Advertising (Pharma Marketing Blog)
What's
really involved in the advertising campaigns for Restless Legs Syndrome treatments,
such as GlaxoSmithKline's Requip? In a humorous and subtly scathing entry, blogger
John Mack muses about this issue.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May